Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Joel McCay
Observed name:
Joel James Robert McCay
Institutions:
Queen Mary University of London,
Barts Cancer Institute
Observed institutions:
Queen Mary University of London,
Royal Free London NHS Foundation Trust,
Hammersmith Hospital,
Barts Cancer Institute
ORCID:
0000-0003-2486-3655
Observed ORCID:
0000-0003-2486-3655
OpenAlex ID:
A5014797827
The role of BTK inhibitors on the tumor microenvironment in CLL
2022
·
Joel McCay
, John G. Gribben
·
Leukemia & lymphoma/Leukemia and lymphoma
·
8
Comparative Assessment of Whole Organ Tissue Processing Methods for the Isolation of Extracellular Vesicles From Intact Organs
2025
·
Mohammed Tayab Hussain
, Shani Austin‐Williams
, et al.
·
Journal of Extracellular Vesicles
·
4
PDF
Type 1 cryoglobulinaemia presenting as digital ischaemia in chronic lymphocytic leukaemia
2018
·
Joel McCay
, Joseph Scott
·
BMJ Case Reports
·
3
PDF
Improvement in mortality of hospitalized patients with hematological malignancies in the 2nd wave of COVID-19 in the UK: experience of a large London NHS trust
2021
·
Richard Hinton
, George Nesr
, et al.
·
Leukemia & lymphoma/Leukemia and lymphoma
·
1
A Retrospective Study into the Use of Prophylactic Antibiotics Pre-Central Venous Catheter Insertion and the Associated Patient Outcomes
2016
·
Joel McCay
, Jonathan Louden
·
Journal of Nephrology & Therapeutics
·
1
PI 3 Kinase, AKT , and m TOR Inhibitors
2023
·
Joel McCay
, John G. Gribben
·
Wiley eBooks
Show more works
View as search
Works count:
6
Citation count:
17
H-index:
3
I10-index:
Year
Topic
Type